首页 / 院系成果 / 成果详情页

Serological Identification of URGCP as a Potential Biomarker for Glioma 期刊论文

编号：

c112440e-ef1c-47bc-a325-66dc14ccd311
作者：

Chen, LingChao(陈灵朝)#^[1]Zhang, HaiYan^[2];Qin, ZhiYong(秦智勇)^[1]Wang, Yang(汪洋)^[1]Mao, Ying(毛颖)^[1]Yao, Yu(姚瑜)^[1]Zhou, LiangFu(周良辅)*^[1]
语种：

English
期刊：

CNS NEUROSCIENCE & THERAPEUTICS ISSN：1755-5930 2014 年 20 卷 4 期 (301 - 307) ; APR
收录：
关键词：

URGCP GBM A2B5 SEREX
摘要：

Aim Glioblastoma multiforme (GBM) is one of the most frequent human brain tumor and causes dismal outcome. To identify tumor-associated antigens in GBM patients may find potential diagnostic markers and immunotherapeutic targets. In this study, we identified a gene termed URGCP using the serological identification of antigens by recombinant A2B5 positive glioma cDNA library. The gene product of URGCP is immunogenic in GBM after tested in allogenic patients serum screening. Methods and results GBM patients with an auto-antibody response against URGCP show longer survival than those without URGCP response. In additional, we show that URGCP was high expression in most GBM tissues and cell lines compared with normal brain tissues and majorly co-expressed with stem cell marker A2B5. Conclusion We identified a potential new biomarker of GBM, URGCP. The findings indicate that URGCP is immunogenic in human GBM and suggest its potential use as diagnostic and immunotherapeutic for GBM patients.
推荐引用方式
GB/T 7714：

Chen Ling-Chao,Zhang Hai-Yan,Qin Zhi-Yong, et al. Serological Identification of URGCP as a Potential Biomarker for Glioma [J].CNS NEUROSCIENCE & THERAPEUTICS,2014,20(4):301-307.
APA：

Chen Ling-Chao,Zhang Hai-Yan,Qin Zhi-Yong,Wang Yang,&Zhou Liang-Fu.(2014).Serological Identification of URGCP as a Potential Biomarker for Glioma .CNS NEUROSCIENCE & THERAPEUTICS,20(4):301-307.
MLA：

Chen Ling-Chao, et al. "Serological Identification of URGCP as a Potential Biomarker for Glioma" .CNS NEUROSCIENCE & THERAPEUTICS 20,4(2014):301-307.

浏览次数：3  下载次数：0

分享到：

浏览次数：3

下载次数：0

打印次数：0